TrialAnnals of medicine2025

Pan-immune-inflammation value predicts survival of patients with oesophageal squamous cell carcinoma receiving immunotherapy and chemoradiotherapy: a pooled analysis of two phase II trials.

Xingyuan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.